Hutch News
Results per Page:
ASCO 2023 highlights: Fine-tuning cancer care
Annual oncology meeting emphasizes less-toxic treatments, more precision oncology and new ways to reduce collateral damage
Tip Sheet: Latest research on COVID-19, health disparities, antibodies to parainfluenza, and neuron function
Summaries of recent Fred Hutch research findings and other news
ASCO endorses integrative oncology guidelines for breast cancer patients
Yoga, meditation, acupuncture and more can be safely used to relieve side effects of standard treatment
Biologics and biosimilars step onto the cancer therapy stage
Q&A: Oncologist and health economist Dr. Gary Lyman discusses a class of treatments on the rise. Will prices follow?
Top cancer organizations make recommendations to erase health disparities
Four national organizations push for richer data, more inclusive research to better serve the underserved
‘Finding their calling’: Cancer caregivers join larger cause after helping loved ones
Some family caregivers devote their lives to that larger work, shifting the health care landscape
Big takeaways from ASCO cancer conference: immunotherapy, precision medicine and more
Immunotherapy, precision medicine and patient-powered research among the highlights of the world’s largest cancer conference
Good News at Fred Hutch
<p>Dr. Amanda Paulovich wins proteomic sciences award; Dr. David Coffey receives ASH research training award; endowed chair named in honor of the late Dr. Stephen Petersdorf</p>
Fred Hutchinson Cancer Research Center researcher Veena Shankaran to receive ‘40 Under 40’ award
Puget Sound Business Journal will honor Shankaran and others as top leaders in their fields
Antibody-Targeted Chemotherapy with Mylotarg Shows Promise for Many Adults with Deadly Form of Leukemia
Fred Hutchinson Cancer Research Center Researcher Presents Updated Study Results at the American Society of Clinical Oncology Meeting in New Orleans